Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 8/2018

01-08-2018 | Capsule Commentary

Capsule Commentary on Silvestri et al., Impact of Cost Display on Ordering Patterns for Hospital Laboratory and Imaging Services

Author: Joseph A. Ladapo, MD, PhD

Published in: Journal of General Internal Medicine | Issue 8/2018

Login to get access

Excerpt

Silvestri et al. evaluated an economics-based intervention that is relatively innovative in healthcare but would be considered commonsense in other fields—namely, providing buyers (physicians) with information about costs of the services they purchase.1 Using a pre-post design, they found that displaying costs in the EHR for lab and imaging tests was associated with a decrease in the number of studies ordered for hospitalized patients and a decrease in overall lab and imaging costs. …
Literature
1.
Silvestri MT, Xu X, Long T, Bongiovanni T, Bernstein SL, Chaudhry SI, Silvestri JI, Stolar M, Greene EJ, Dziura JD, Gross CP, Krumholz HM. Impact of Cost Display on Ordering Patterns for Hospital Laboratory and Imaging Services. J Gen Intern Med. DOI: https://​doi.​org/​10.​1007/​s11606-018-4495-6.
2.
Kenneth JA. ‘The economics of agency’ in Principals and agents: The structure of business. In: Pratt JW, Zeckhauser RJ, eds. Boston: Harvard Business School Press;1985:37–51.
3.
Kim J, Novemsky N, Dhar R. Adding small differences can increase similarity and choice. Psychol Sci 2013;24(2):225–229.CrossRefPubMed
4.
Anderson ET, Simester DI. Effects of $9 Price Endings on Retail Sales: Evidence from Field Experiments. Quant Mark Econ 2003;1(1):93–110.CrossRef
Metadata
Title
Capsule Commentary on Silvestri et al., Impact of Cost Display on Ordering Patterns for Hospital Laboratory and Imaging Services
Author
Joseph A. Ladapo, MD, PhD
Publication date
01-08-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 8/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4516-5

Other articles of this Issue 8/2018

Journal of General Internal Medicine 8/2018 Go to the issue

Original Research

Effect of Low Back Pain Risk-Stratification Strategy on Patient Outcomes and Care Processes: the MATCH Randomized Trial in Primary Care

Letter to the Editor

Design and Interpretation of Noninferiority Trials

Concise Research Reports

Virtual First Responders: the Role of Direct-to-Consumer Telemedicine in Caring for People Impacted by Natural Disasters

Healing Arts: Materia Medica

On the Value of the Primary Care Physician

Original Research

Primary Care Clinicians’ Views About the Impact of Medicaid Expansion in Michigan: A Mixed Methods Study

Concise Research Reports

Evaluation of Pharmacist Involvement in Outpatient Transitions of Care
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits